Re: Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial
Eur Urol
.
2024 Aug 17:S0302-2838(24)02523-5.
doi: 10.1016/j.eururo.2024.08.006.
Online ahead of print.
Author
Ola Bratt
1
Affiliation
1
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address:
[email protected]
.
PMID:
39153930
DOI:
10.1016/j.eururo.2024.08.006
No abstract available